Accessibility Statement

Last updated: July 24, 2026 · MyPeptide research website

MyPeptide is committed to making this website usable by as many people as possible, including people with disabilities. We aim to conform to the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA and applicable ADA-related digital accessibility expectations.

Measures we take

Semantic structure and a main content landmark for assistive technologies
Skip to main content link for keyboard users
Visible focus indicators on interactive controls
Document language set to English (lang="en")
Responsive, mobile-first layout with readable type and touch-friendly targets where practical (≈44×44px)
Images: meaningful alt text where content-bearing; decorative images marked appropriately
Cookie consent dialog: keyboard operable, screen-reader labels, focus management, no keyboard trap outside intended modal behavior
Respect for prefers-reduced-motion and improved contrast preferences where supported
Meta viewport configured for mobile devices without disabling user zoom

Mobile optimization

Layouts adapt across phone, tablet, and desktop breakpoints
Horizontal overflow is constrained; media scales within the viewport
Form controls use font sizes that reduce unwanted mobile zoom on focus
Safe-area padding considered for notched devices on key UI (e.g. consent banner)

Known limitations

We continue to improve contrast, labeling, and keyboard paths as we iterate. Some third-party fonts or complex interactive components may not yet meet every AA criterion in every browser.

How we test

Keyboard-only navigation (Tab / Shift+Tab / Enter / Escape)
Screen reader spot checks (VoiceOver / NVDA where available)
Browser zoom to 200%
Recommended tools: Lighthouse Accessibility, axe DevTools, WAVE

Feedback

If you encounter an accessibility barrier, please contact support@mypeptide.net with the page URL and a description of the issue. We will work to provide information in an accessible format and improve the site.